Vividion Therapeutics
Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
About
Technology stack
detected 2026-06-17No comments yet. Be the first to share your take.
What does Vividion Therapeutics do?
Vividion Therapeutics is a biopharmaceutical company that utilizes novel discovery technologies to unlock high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders. Their platform combines chemoproteomics and covalent chemistry to identify and develop small molecule drugs for diseases with unmet medical needs. Vividion operates as a wholly owned, independently operated subsidiary of Bayer AG.
How much funding has Vividion Therapeutics raised?
Vividion Therapeutics has raised a total of $267M in funding. The most recent round on record is Series C.
Where is Vividion Therapeutics headquartered?
Vividion Therapeutics is headquartered in San Diego, United States.
When was Vividion Therapeutics founded?
Vividion Therapeutics was founded in 2017.
What industry does Vividion Therapeutics operate in?
Vividion Therapeutics operates in Biotech, Drug Discovery, Oncology, Therapeutics, Chemoproteomics, Precision Medicine.
How many employees does Vividion Therapeutics have?
Vividion Therapeutics has approximately 265 people on record.